Outsourcing: your strategic decision

Strategic outsourcing is a growing trend in the pharmaceutical industry. There are many good reasons for entering in a partnership with Labo Smeets.

Powder products don't always have the critical mass to be profitable in your operation. Our focus can be of help for you.

Cost-savings 

You concentrate on your core business; we concentrate on specific activities that seamlessly supplement your efforts. In the case of production peaks, new developments, limited editions… we make it easy for you to extend your capacity without investment risks.

 Flexibility

The market demands thorough and continuous innovation. The time to market is becoming increasingly shorter, the deadlines tighter. Together with us, you are continually on top of things. This maximises your operations and your competitiveness.

State-of-the-art equipment

Technology is evolving rapidly. Keeping up with the latest technologies and equipment for powder manufacturing is not always easy – or justifiable from a business point of view. As specialists in the production and packaging of (para)pharmaceuticals, we make the investments for you.

Strategic partnership

We enter in a partnership with our clients that is supported by four pillars: excellence, confidence, flexibility and transparency. We do not sell proprietary products, we do not market products under our own name. All of this underpins our long-term alliances with our clients.

LABORATORIA SMEETS N.V.

Fotografielaan 42
B-2610 Antwerpen-Wilrijk
Tel. +32 (0)3 828 29 37
Fax +32 (0)3 830 21 36
e-mail: info@labosmeets.be

EN  NL  FR  DE  ES 
CASE:  

Read more...

Read more...
CASE: New Technology for API solubility  

In collaboration with the University of Ghent, Labo Smeets has realised a new process in pharmaceutical extrusion technology, which enables us to make highly soluble granules. The main application is to make pharmaceutical granule compositions to drastically improve water solubility of active ingredients. The technology is applicable for the following drug ...
Read more...
New Technology for API solubility

In collaboration with the University of Ghent, Labo Smeets has realised a new process in pharmaceutical extrusion technology, which enables us to make granules. The main application is to make pharmaceutical granule compositions to drastically improve water solubility of active ingredients. This equipment is installed and available since January 2011.

Read more...
CASE: Product innovation  

A customer identified a patented technology at one of the Belgian universities to make one of their products easier to administer. We were contacted at an early stage to help with developing the product. We jointly decided to set up a test manufacturing unit in order to produce small batches for the clinical trials. As the project outcome was uncertain, ...
Read more...
CASE: Strategic procurement  

One of  our pharmacuetical customers is a large consumer of raw materials. Often large pharmaceutical customers are constrained with their raw materials procurement strategies. The complexity of the regulatory filing for many of their products, prevents them from obtaining the best deal. Underlying causes are the intrinsic speed of action, but also the ...
Read more...
CASE: International  

A potential customer outside the European Union contacted Laboratoria Smeets. He had obtained, sooner than expected, a registration for his powder product and was desperately seeking to be on the market as soon as possible. We immediately shared his sense of urgency. Just one day after the initial contact, we offered a full service proposal to buy the ...
Read more...